Tribbles 2 confers enzalutamide resistance in prostate cancer by promoting lineage plasticity.
J. Monga, I. Adrianto, C. Rogers, S. Gadgeel, D. Chitale, J. Alumkal, H. Beltran, A. Zoubeidi, J. Ghosh
This study identifies Tribbles 2 as a driver of enzalutamide resistance in prostate cancer by promoting lineage plasticity and neuroendocrine differentiation.
bioRxiv · Mar 26, 2021Cancer Biology